Literature DB >> 16227599

Class IA phosphoinositide 3-kinase regulates heart size and physiological cardiac hypertrophy.

Ji Luo1, Julie R McMullen, Cassandra L Sobkiw, Li Zhang, Adam L Dorfman, Megan C Sherwood, M Nicole Logsdon, James W Horner, Ronald A DePinho, Seigo Izumo, Lewis C Cantley.   

Abstract

Class I(A) phosphoinositide 3-kinases (PI3Ks) are activated by growth factor receptors, and they regulate, among other processes, cell growth and organ size. Studies using transgenic mice overexpressing constitutively active and dominant negative forms of the p110alpha catalytic subunit of class I(A) PI3K have implicated the role of this enzyme in regulating heart size and physiological cardiac hypertrophy. To further understand the role of class I(A) PI3K in controlling heart growth and to circumvent potential complications from the overexpression of dominant negative and constitutively active proteins, we generated mice with muscle-specific deletion of the p85alpha regulatory subunit and germ line deletion of the p85beta regulatory subunit of class I(A) PI3K. Here we show that mice with cardiac deletion of both p85 subunits exhibit attenuated Akt signaling in the heart, reduced heart size, and altered cardiac gene expression. Furthermore, exercise-induced cardiac hypertrophy is also attenuated in the p85 knockout hearts. Despite such defects in postnatal developmental growth and physiological hypertrophy, the p85 knockout hearts exhibit normal contractility and myocardial histology. Our results therefore provide strong genetic evidence that class I(A) PI3Ks are critical regulators for the developmental growth and physiological hypertrophy of the heart.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16227599      PMCID: PMC1265829          DOI: 10.1128/MCB.25.21.9491-9502.2005

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  55 in total

1.  A friend within the heart: natriuretic peptide receptor signaling.

Authors:  Jeffery D Molkentin
Journal:  J Clin Invest       Date:  2003-05       Impact factor: 14.808

2.  The FOXO3a transcription factor regulates cardiac myocyte size downstream of AKT signaling.

Authors:  Carsten Skurk; Yasuhiro Izumiya; Henrike Maatz; Peter Razeghi; Ichiro Shiojima; Marco Sandri; Kaori Sato; Ling Zeng; Stephan Schiekofer; David Pimentel; Stewart Lecker; Heinrich Taegtmeyer; Alfred L Goldberg; Kenneth Walsh
Journal:  J Biol Chem       Date:  2005-03-21       Impact factor: 5.157

Review 3.  Role of phosphoinositide 3-kinase in cardiac function and heart failure.

Authors:  Sathyamangla V Naga Prasad; Cinzia Perrino; Howard A Rockman
Journal:  Trends Cardiovasc Med       Date:  2003-07       Impact factor: 6.677

4.  Pressure-independent cardiac hypertrophy in mice with cardiomyocyte-restricted inactivation of the atrial natriuretic peptide receptor guanylyl cyclase-A.

Authors:  Rita Holtwick; Martin van Eickels; Boris V Skryabin; Hideo A Baba; Alexander Bubikat; Frank Begrow; Michael D Schneider; David L Garbers; Michaela Kuhn
Journal:  J Clin Invest       Date:  2003-05       Impact factor: 14.808

5.  Phosphoinositide 3-kinase(p110alpha) plays a critical role for the induction of physiological, but not pathological, cardiac hypertrophy.

Authors:  Julie R McMullen; Tetsuo Shioi; Li Zhang; Oleg Tarnavski; Megan C Sherwood; Peter M Kang; Seigo Izumo
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-24       Impact factor: 11.205

Review 6.  PTEN: from pathology to biology.

Authors:  Maria Luisa Sulis; Ramon Parsons
Journal:  Trends Cell Biol       Date:  2003-09       Impact factor: 20.808

7.  Insulin activation of Rheb, a mediator of mTOR/S6K/4E-BP signaling, is inhibited by TSC1 and 2.

Authors:  Attila Garami; Fried J T Zwartkruis; Takahiro Nobukuni; Manel Joaquin; Marta Roccio; Hugo Stocker; Sara C Kozma; Ernst Hafen; Johannes L Bos; George Thomas
Journal:  Mol Cell       Date:  2003-06       Impact factor: 17.970

Review 8.  Cardiac hypertrophy: the good, the bad, and the ugly.

Authors:  N Frey; E N Olson
Journal:  Annu Rev Physiol       Date:  2003-01-09       Impact factor: 19.318

9.  Deficiency of PDK1 in cardiac muscle results in heart failure and increased sensitivity to hypoxia.

Authors:  Alfonso Mora; Anthony M Davies; Luc Bertrand; Isam Sharif; Grant R Budas; Sofija Jovanović; Véronique Mouton; C Ronald Kahn; John M Lucocq; Gillian A Gray; Aleksandar Jovanović; Dario R Alessi
Journal:  EMBO J       Date:  2003-09-15       Impact factor: 11.598

10.  Tuberous sclerosis complex gene products, Tuberin and Hamartin, control mTOR signaling by acting as a GTPase-activating protein complex toward Rheb.

Authors:  Andrew R Tee; Brendan D Manning; Philippe P Roux; Lewis C Cantley; John Blenis
Journal:  Curr Biol       Date:  2003-08-05       Impact factor: 10.834

View more
  83 in total

1.  Phosphoinositide 3-kinase signaling mediates beta-catenin activation in intestinal epithelial stem and progenitor cells in colitis.

Authors:  Goo Lee; Tatiana Goretsky; Elizabeth Managlia; Ramanarao Dirisina; Ajay Pal Singh; Jeffrey B Brown; Randal May; Guang-Yu Yang; Josette William Ragheb; B Mark Evers; Christopher R Weber; Jerrold R Turner; Xi C He; Rebecca B Katzman; Linheng Li; Terrence A Barrett
Journal:  Gastroenterology       Date:  2010-05-24       Impact factor: 22.682

Review 2.  Electrical and mechanical stimulation of cardiac cells and tissue constructs.

Authors:  Whitney L Stoppel; David L Kaplan; Lauren D Black
Journal:  Adv Drug Deliv Rev       Date:  2015-07-30       Impact factor: 15.470

Review 3.  Cardiovascular Adaptations Induced by Resistance Training in Animal Models.

Authors:  S F S Melo; N D da Silva Júnior; V G Barauna; E M Oliveira
Journal:  Int J Med Sci       Date:  2018-02-12       Impact factor: 3.738

4.  PI3K-p110α mediates the oncogenic activity induced by loss of the novel tumor suppressor PI3K-p85α.

Authors:  Lauren M Thorpe; Jennifer M Spangle; Carolynn E Ohlson; Hailing Cheng; Thomas M Roberts; Lewis C Cantley; Jean J Zhao
Journal:  Proc Natl Acad Sci U S A       Date:  2017-06-19       Impact factor: 11.205

5.  Protective effects of exercise and phosphoinositide 3-kinase(p110alpha) signaling in dilated and hypertrophic cardiomyopathy.

Authors:  Julie R McMullen; Fatemeh Amirahmadi; Elizabeth A Woodcock; Martina Schinke-Braun; Russell D Bouwman; Kimberly A Hewitt; Janelle P Mollica; Li Zhang; Yunyu Zhang; Tetsuo Shioi; Antje Buerger; Seigo Izumo; Patrick Y Jay; Garry L Jennings
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-03       Impact factor: 11.205

6.  Overexpression of bone morphogenetic protein 10 in myocardium disrupts cardiac postnatal hypertrophic growth.

Authors:  Hanying Chen; Weidong Yong; Shuxun Ren; Weihua Shen; Yongzheng He; Karen A Cox; Wuqiang Zhu; Wei Li; Mark Soonpaa; R Mark Payne; Diego Franco; Loren J Field; Vicki Rosen; Yibin Wang; Weinian Shou
Journal:  J Biol Chem       Date:  2006-06-23       Impact factor: 5.157

7.  Sjögren's syndrome-like disease in mice with T cells lacking class 1A phosphoinositide-3-kinase.

Authors:  Jean S Oak; Jonathan A Deane; Michael G Kharas; Ji Luo; Thomas E Lane; Lewis C Cantley; David A Fruman
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-27       Impact factor: 11.205

Review 8.  Molecular basis of physiological heart growth: fundamental concepts and new players.

Authors:  Marjorie Maillet; Jop H van Berlo; Jeffery D Molkentin
Journal:  Nat Rev Mol Cell Biol       Date:  2013-01       Impact factor: 94.444

9.  Acute effects of leptin require PI3K signaling in hypothalamic proopiomelanocortin neurons in mice.

Authors:  Jennifer W Hill; Kevin W Williams; Chianping Ye; Ji Luo; Nina Balthasar; Roberto Coppari; Michael A Cowley; Lewis C Cantley; Bradford B Lowell; Joel K Elmquist
Journal:  J Clin Invest       Date:  2008-05       Impact factor: 14.808

Review 10.  Status of PI3K/Akt/mTOR pathway inhibitors in lymphoma.

Authors:  Jason R Westin
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2014-02-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.